<DOC>
	<DOCNO>NCT00385502</DOCNO>
	<brief_summary>Approximately 40 qualified subject mild-to-moderate great toenail fungus infection treat 48 week lacquer application least one affected great toenail . All subject receive treatment EcoNail™ lacquer .</brief_summary>
	<brief_title>A Trial Safety Efficacy EcoNail™ Treatment Fungus Infections Great Toenail</brief_title>
	<detailed_description>This study use multi-center , open-label study design subject onychomycosis least one great toenail ass safety , local tolerability , efficacy chronic daily ungual application EcoNail™ . Forty ( 40 ) evaluable subject apply study drug daily least one affected great toenail 48 week . The subject must comply inclusion exclusion criterion .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Econazole</mesh_term>
	<criteria>Subjects men woman great equal 18 year age less equal 65 year age . Female subject postmenopausal ( amenorrheic least 1 year ) , surgically sterile , partner vasectomy , routinely use acceptable mean contraception ( acceptable method may include hormonal contraceptive , intrauterine device , spermicide barrier , abstinence partner/spouse sterility ) . Subjects mycologically confirm distal subungual onychomycosis least one great toenail ( `` target toenail '' ) , define positive result officebased KOH preparation ( ± Chlorazol B ) laboratory culture demonstrate one follow organism : T. rubrum , T. mentagrophytes , T. tonsurans and/or E. floccosum Subjects target toenail show 2065 % ( +/ 2 % ) involvement judge clinical investigator . Subjects target toenail showing great equal 3 mm distal involvement judge clinical investigator . Subjects target toenail showing great equal 2 mm proximal clear nail cuticle . Subjects must agree apply nail polish relate product affect nails duration study . Subjects must refrain filing , clip , otherwise disturb treat nail ( ) duration study [ NOTE : Clinic personnel debride affect nail monthly visit . Subjects engage activity home course study . ] Subjects must ability understand nature study hazard participate willingness communicate satisfactorily investigator staff participate , comply requirement entire study . Subjects must able read sign study Informed Consent form comply requirement outline informed consent form . Subjects &lt; 20 % &gt; 65 % ( +/ 2 % ) involvement target toenail . Subjects great equal 4 mm thickness target toenail . Subjects totally dystrophic great toe . Subjects great toenail show white superficial proximal subungual onychomycosis , `` spike '' onychomycosis extend cuticle . Subjects whose nail culture grow Candida specie pathogen . Subjects report treatment topical antifungal agent onychomycosis four week prior screen study . Subjects treat systemic antifungal agent three month prior screen study . Subjects nail abnormality dermatological condition , include ( limited ) psoriasis lichen planus , could prevent obtain normalappearing toenail complete cure achieve could otherwise interfere require study assessment . Subjects history organ transplantation , Human Immunodeficiency Virus ( HIV ) seropositivity historical clinical evidence immunocompromised state . Subjects history uncontrolled insulindependent diabetes mellitus . Subjects history diabetic peripheral neuropathy . Subjects history clinically significant low extremity peripheral occlusive vascular disease . Subjects presence plantar ( moccasin ) tinea pedis . Subjects history hypersensitivity allergic reaction skin nail , include reaction nail polish and/or nail polish remover . Subjects know allergy econazole , ethanol , Eudragit , SEPA . Female subject pregnant lactating . Subjects clinically relevant abnormal history , physical finding , laboratory value screen assessment could interfere objective safety volunteer . Subjects condition abnormality investigator 's opinion may interfere assessment , conduct study , may affect subject 's safety , otherwise unsuitable enrollment . Subjects currently participate , within previous 30 day , participate another investigational drug study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>toenail</keyword>
	<keyword>fungus</keyword>
	<keyword>onychomycosis</keyword>
	<keyword>antifungal</keyword>
	<keyword>anti-fungal</keyword>
	<keyword>nail</keyword>
</DOC>